Table 1 Distribution of sociodemographic, lifestyle, and clinical variables according to the appendicular skeletal muscle mass index of postmenopausal women
Variables n = 114 | ASMI (kg/m2) | ||||
|---|---|---|---|---|---|
Total n (%) | 1st Tertile (n = 38) (5.68 ± 0.31) | 2nd Tertile (n = 38) (6.72 ± 0.28) | 3rd Tertile (n = 38) (7.78 ± 0.53) | p value* | |
Age (years) | 0.027 | ||||
 50.0–59.9 | 15 (13.2) | 2 (13.3) | 4 (26.7) | 9 (60.0) |  |
 60.0–69.9 | 71 (62.3) | 22 (31.0) | 24 (33.8) | 25 (35.2) |  |
  ≥ 70.0 | 28 (24.6) | 14 (50.0) | 10 (35.7) | 4 (14.3) |  |
Marital status | 0.358 | ||||
 Lives with partner | 59 (51.8) | 21 (35.6) | 16 (27.1) | 22 (37.3) |  |
 Lives without partner | 55 (48.2) | 17 (30.9) | 22 (40.0) | 16 (29.1) |  |
Race/color | 0.582 Ŧ | ||||
 White | 43 (37.7) | 15 (34.9) | 16 (37.2) | 12 (27.9) |  |
 Black | 9 (7.9) | 2 (22.2) | 4 (44.4) | 3 (33.3) |  |
 Yellow | 6 (5.3) | 4 (66.7) | 1 (16.7) | 1 (16.7) |  |
 Brown | 56 (49.1) | 17 (30.4) | 17 (30.4) | 22 (39.3) |  |
Education | 0.096 | ||||
  < 4 years | 47 (41.2) | 17 (36.2) | 12 (25.5) | 18 (38.3) |  |
 4–8 years | 32 (28.1) | 8 (25.0) | 17 (53.1) | 7 (21.9) |  |
  > 8 years | 35 (30.7) | 13 (37.1) | 9 (25.8) | 13 (37.1) |  |
Smoking | 0.569 Ŧ | ||||
 Never smoked | 79 (69.3) | 27 (34.2) | 28 (35.4) | 24 (30.4) |  |
 Make use | 6 (5.3) | 3 (50.0) | 2 (33.3) | 1 (16.7) |  |
 Ex smoker | 29 (25.4) | 8 (27.6) | 8 (27.6) | 13 (44.8) |  |
Alcohol consumption | 0.830 | ||||
 Never consumed | 72 (63.2) | 26 (36.1) | 23 (31.9) | 23 (31.9) |  |
 Consume | 15 (13.2) | 5 (33.3) | 4 (26.7) | 6 (40.0) |  |
 Consumed in the past | 27 (23.7) | 7 (25.9) | 11 (40.7) | 9 (33.3) |  |
Physical Activity Level | 0.629 Ŧ | ||||
 Insufficiently active | 53 (46.5) | 19 (35.8) | 19 (35.8) | 15 (28.3) |  |
 Sufficiently active | 61 (53.5) | 19 (31.1) | 19 (31.1) | 23 (37.7) |  |
Menopause Time | 0.299 | ||||
  ≤ 19 years old | 59 (51.8) | 16 (27.1) | 20 (33.9) | 23 (39.0) |  |
  > 19 years old | 55 (48.2) | 22 (40.0) | 18 (32.7) | 15 (27.3) |  |
Number of comorbidities | 1.000 | ||||
 1 to 3 comorbidities | 85 (74.6) | 28 (32.9) | 29 (34.1) | 28 (32.9) |  |
  ≥ 4 comorbidities | 29 (25.4) | 10 (34.5) | 9 (31.0) | 10 (34.5) |  |
Polypharmacy | 0.164 | ||||
 1 to 4 medications | 66 (57.9) | 27 (40.9) | 20 (30.3) | 19 (28.8) |  |
  ≥ 5 medications | 48 (42.1) | 11 (22.9) | 18 (37.5) | 19 (39.6) |  |
Calcium supplementation | 0.105 | ||||
 Make use | 68 (59.6) | 28 (41.2) | 20 (29.4) | 20 (29.4) |  |
 Does not use | 46 (40.4) | 10 (21.7) | 18 (39.1) | 18 (39.1) |  |